355 related articles for article (PubMed ID: 3802423)
21. The effects of H1 and H2 histamine receptor antagonists on the development of endotoxemia in the conscious, unrestrained rat.
Brackett DJ; Schaefer CF; Wilson MF
Circ Shock; 1985; 16(2):141-53. PubMed ID: 2414028
[TBL] [Abstract][Full Text] [Related]
22. Comparative hemodynamics and cardiovascular effects of endotoxin and platelet-activating factor in rat.
Salari H; Demos M; Wong A
Circ Shock; 1990 Nov; 32(3):189-207. PubMed ID: 2261677
[TBL] [Abstract][Full Text] [Related]
23. PAF, rather than histamine, participates in mouse anaphylactic hypotension.
Shibamoto T; Liu W; Cui S; Zhang W; Takano H; Kurata Y
Pharmacology; 2008; 82(2):114-20. PubMed ID: 18583921
[TBL] [Abstract][Full Text] [Related]
24. Evidence that platelet activating factor may mediate some acute inflammatory responses. Studies with the platelet-activating factor antagonist, CV3988.
Issekutz AC; Szpejda M
Lab Invest; 1986 Mar; 54(3):275-81. PubMed ID: 3951199
[TBL] [Abstract][Full Text] [Related]
25. Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats.
Chang SW; Feddersen CO; Henson PM; Voelkel NF
J Clin Invest; 1987 May; 79(5):1498-509. PubMed ID: 3553241
[TBL] [Abstract][Full Text] [Related]
26. Phenylephrine ameliorates cerebral cytotoxic edema and reduces cerebral infarction volume in a rat model of complete unilateral carotid artery occlusion with severe hypotension.
Ishikawa S; Ito H; Yokoyama K; Makita K
Anesth Analg; 2009 May; 108(5):1631-7. PubMed ID: 19372348
[TBL] [Abstract][Full Text] [Related]
27. Gastrointestinal plasma leakage in endotoxic shock. Inhibition by prostaglandin E2 and by a platelet-activating factor antagonist.
Wallace JL; Steel G; Whittle BJ
Can J Physiol Pharmacol; 1987 Jul; 65(7):1428-32. PubMed ID: 3478114
[TBL] [Abstract][Full Text] [Related]
28. Beneficial effects of (RS)-2-methoxy-3-(octadecylcarbamoyloxy)propyl 2-(3-thiazolio)ethyl phosphate, a specific PAF antagonist, in endotoxin and anaphylactic shock.
Terashita Z; Imura Y; Nishikawa K; Sumida S
Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():715-7. PubMed ID: 3004156
[No Abstract] [Full Text] [Related]
29. Inhibition of antigen-induced airway hyperresponsiveness in rats: effects of ozagrel (a thromboxane A2 synthase inhibitor) and of CV-3988 (a platelet activating factor antagonist).
Misawa M; Chiba Y
Res Commun Chem Pathol Pharmacol; 1994 Jun; 84(3):341-9. PubMed ID: 7938906
[TBL] [Abstract][Full Text] [Related]
30. Platelet-activating factor antagonist TCV-309 attenuates the induction of the cytokine network in experimental endotoxemia in chimpanzees.
Kuipers B; van der Poll T; Levi M; van Deventer SJ; ten Cate H; Imai Y; Hack CE; ten Cate JW
J Immunol; 1994 Mar; 152(5):2438-46. PubMed ID: 8133055
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological actions of PCA 4248, a new platelet-activating factor receptor antagonist: in vivo studies.
Fernández-Gallardo S; Ortega MP; Priego JG; de Casa-Juana MF; Sunkel C; Sánchez Crespo M
J Pharmacol Exp Ther; 1990 Oct; 255(1):34-9. PubMed ID: 2170626
[TBL] [Abstract][Full Text] [Related]
32. Platelet activating factor impairs pressor responses to noradrenaline in the anaesthetized rat but does not mediate endotoxin-induced hyporeactivity.
Bouvier C; Guc MO; Furman BL; Parratt JR
Circ Shock; 1994 Jan; 42(1):14-9. PubMed ID: 8149505
[TBL] [Abstract][Full Text] [Related]
33. [Effect of an extract from the cauline of Piper kadsura ohwi on endotoxin-induced hypotension and lung injury in rats].
Li SH; Fei X; Wu ZL; Cheng SF
Zhongguo Zhong Yao Za Zhi; 1989 Nov; 14(11):683-5, 704. PubMed ID: 2619897
[TBL] [Abstract][Full Text] [Related]
34. Effect of LTB4 receptor antagonists in endotoxic shock in the rat.
Li EJ; Cook JA; Wise WC; Jackson WT; Halushka PV
Circ Shock; 1991 Aug; 34(4):385-92. PubMed ID: 1663429
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological activities of a novel thienodiazepine derivative as a platelet-activating factor antagonist. Effects on microvascular permeability, hypotension and nephrosis.
Sakuma Y; Shirato M; Nagaoka J; Obaishi H; Tsunoda H; Katayama S; Ono H; Katayama K
Arzneimittelforschung; 1991 Dec; 41(12):1255-9. PubMed ID: 1815526
[TBL] [Abstract][Full Text] [Related]
36. Cardiovascular responses to exogenous platelet-activating factor (PAF) in anesthetized ponies, and the effects of a PAF antagonist, WEB 2086.
Wilson DV; Eberhart SW; Robinson NE; Rice R; Gray PR
Am J Vet Res; 1993 Feb; 54(2):274-9. PubMed ID: 8430938
[TBL] [Abstract][Full Text] [Related]
37. Endotoxic shock elicits greater endorphin secretion than hemorrhage.
Hamilton AJ; Carr DB; LaRovere JM; Black PM
Circ Shock; 1986; 19(1):47-54. PubMed ID: 2941182
[TBL] [Abstract][Full Text] [Related]
38. Biological effects of the new platelet-activating factor receptor antagonist (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride.
Imanishi N; Murakami-Uchida M; Koike H; Natsume Y; Morooka S
Arzneimittelforschung; 1994 Mar; 44(3):317-22. PubMed ID: 8192697
[TBL] [Abstract][Full Text] [Related]
39. Effects of palmitoyl carnitine and structural analogs on arterial blood pressure in the rat. A comparison with platelet-activating factor.
Man RY; Hu WM; Mock T; Kinnaird AA
J Lipid Mediat; 1991; 3(2):205-14. PubMed ID: 1686730
[TBL] [Abstract][Full Text] [Related]
40. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF).
Merlos M; Giral M; Balsa D; Ferrando R; Queralt M; Puigdemont A; García-Rafanell J; Forn J
J Pharmacol Exp Ther; 1997 Jan; 280(1):114-21. PubMed ID: 8996188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
